Partners

Strategic partnerships will allow us to reach our goals

Grants

2012-2017
ERC Grant

New data generation
& Application of 2
European Patents

2012-2017
2016-2017
ERC PoC

PoC Validation

2016-2017
2017-2019
DTS

Biomarker Validation

2017-2019
2019
MAP Program
EADA Business school

Market analysis &
Financial validation

2019
2020
CRAASH Barcelona

Program that helps European research teams launch successful diagnostic innovations to improve health and patient care

2020
2020
FIPSE

Ayudas para financiar estudios de viabilidad de las innovaciones en Salud

2020

Collaborators

Attorney Officer

Chief Financial Officer

Investors

AtG’s business model consists of de-risking AtG-101 and its Companion Diagnostic from a Proof of Concept Development Stage into a successful Phase I/II product and then Licensing it to a Pharmaceutical company.

AtG is currently looking for investors in order to fund the preclinical development of AtG-101.

Would it be you?